Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
The researchers sought to evaluate the relationship between pain management and stimulant use in people with chronic pain.
Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.
Data analysis revealed that CGRP mAbs were discontinued more frequently than onabotulinumtoxinA (23% vs 3%).
Hizentra is indicated for the treatment of adult patients with CIDP as maintenance therapy to prevent relapse of neuromuscular disability and impairment.
Percutaneous peripheral nerve stimulation reduces acute pain and opioid requirements in the week following orthopedic surgery.
The main goal of this study was to characterize sex differences and abnormalities in the functional segregation and integration of the whole-brain network architecture associated with chronic pain.
Researchers believed the MIDAS questionnaire would improve communication and aid in the diagnosis of migraines.
Study investigators sought to determine whether acute treatment with rimegepant decreases analgesic or antiemetic use in people with migraine.
Magnesium’s potential action as a voltage-gated antagonist of N-methyl-D-aspartate receptors to mediate pain transduction is reviewed here.
